UniProt ID | VPS18_HUMAN | |
---|---|---|
UniProt AC | Q9P253 | |
Protein Name | Vacuolar protein sorting-associated protein 18 homolog | |
Gene Name | VPS18 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 973 | |
Subcellular Localization |
Late endosome membrane Peripheral membrane protein Cytoplasmic side . Lysosome membrane Peripheral membrane protein Cytoplasmic side . Early endosome . Cytoplasmic vesicle, autophagosome . Cytoplasmic vesicle, clathrin-coated vesicle . Cytopl |
|
Protein Description | Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Believed to act as a core component of the putative HOPS and CORVET endosomal tethering complexes which are proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the late endosomal membrane and to regulate late endocytic, phagocytic and autophagic traffic towards lysosomes. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations. [PubMed: 11382755] | |
Protein Sequence | MASILDEYENSLSRSAVLQPGCPSVGIPHSGYVNAQLEKEVPIFTKQRIDFTPSERITSLVVSSNQLCMSLGKDTLLRIDLGKANEPNHVELGRKDDAKVHKMFLDHTGSHLLIALSSTEVLYVNRNGQKVRPLARWKGQLVESVGWNKALGTESSTGPILVGTAQGHIFEAELSASEGGLFGPAPDLYFRPLYVLNEEGGPAPVCSLEAERGPDGRSFVIATTRQRLFQFIGRAAEGAEAQGFSGLFAAYTDHPPPFREFPSNLGYSELAFYTPKLRSAPRAFAWMMGDGVLYGALDCGRPDSLLSEERVWEYPEGVGPGASPPLAIVLTQFHFLLLLADRVEAVCTLTGQVVLRDHFLEKFGPLKHMVKDSSTGQLWAYTERAVFRYHVQREARDVWRTYLDMNRFDLAKEYCRERPDCLDTVLAREADFCFRQRRYLESARCYALTQSYFEEIALKFLEARQEEALAEFLQRKLASLKPAERTQATLLTTWLTELYLSRLGALQGDPEALTLYRETKECFRTFLSSPRHKEWLFASRASIHELLASHGDTEHMVYFAVIMQDYERVVAYHCQHEAYEEALAVLARHRDPQLFYKFSPILIRHIPRQLVDAWIEMGSRLDARQLIPALVNYSQGGEVQQVSQAIRYMEFCVNVLGETEQAIHNYLLSLYARGRPDSLLAYLEQAGASPHRVHYDLKYALRLCAEHGHHRACVHVYKVLELYEEAVDLALQVDVDLAKQCADLPEEDEELRKKLWLKIARHVVQEEEDVQTAMACLASCPLLKIEDVLPFFPDFVTIDHFKEAICSSLKAYNHHIQELQREMEEATASAQRIRRDLQELRGRYGTVEPQDKCATCDFPLLNRPFYLFLCGHMFHADCLLQAVRPGLPAYKQARLEELQRKLGAAPPPAKGSARAKEAEGGAATAGPSREQLKADLDELVAAECVYCGELMIRSIDRPFIDPQRYEEEQLSWL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASILDEYE ------CCCHHHHHH | 12.79 | 22223895 | |
3 | Phosphorylation | -----MASILDEYEN -----CCCHHHHHHH | 23.53 | 28857561 | |
8 | Phosphorylation | MASILDEYENSLSRS CCCHHHHHHHHCCHH | 21.78 | 25106551 | |
11 | Phosphorylation | ILDEYENSLSRSAVL HHHHHHHHCCHHHHC | 18.78 | 25849741 | |
13 | Phosphorylation | DEYENSLSRSAVLQP HHHHHHCCHHHHCCC | 24.82 | 25849741 | |
14 | Methylation | EYENSLSRSAVLQPG HHHHHCCHHHHCCCC | 33.65 | 115389081 | |
15 | Phosphorylation | YENSLSRSAVLQPGC HHHHCCHHHHCCCCC | 21.25 | 21945579 | |
24 | Phosphorylation | VLQPGCPSVGIPHSG HCCCCCCCCCCCCCC | 36.73 | 21945579 | |
30 | Phosphorylation | PSVGIPHSGYVNAQL CCCCCCCCCCCCCEE | 26.85 | 21945579 | |
32 | Phosphorylation | VGIPHSGYVNAQLEK CCCCCCCCCCCEEEE | 8.11 | 21945579 | |
39 | Ubiquitination | YVNAQLEKEVPIFTK CCCCEEEEECCCEEC | 73.02 | - | |
46 | Ubiquitination | KEVPIFTKQRIDFTP EECCCEECCCCCCCC | 27.16 | - | |
83 | Ubiquitination | LLRIDLGKANEPNHV EEEEECCCCCCCCCC | 56.17 | - | |
224 | Phosphorylation | RSFVIATTRQRLFQF CCEEEEEHHHHHHHH | 18.78 | 24719451 | |
276 | Ubiquitination | ELAFYTPKLRSAPRA HHHHCCHHHCCCCCH | 49.05 | - | |
362 | Acetylation | LRDHFLEKFGPLKHM HCHHHHHHHCCCCCE | 58.74 | 19608861 | |
367 | Ubiquitination | LEKFGPLKHMVKDSS HHHHCCCCCEEECCC | 32.56 | - | |
412 | Ubiquitination | MNRFDLAKEYCRERP CCCHHHHHHHHHHCC | 57.42 | - | |
476 | Ubiquitination | LAEFLQRKLASLKPA HHHHHHHHHHCCCHH | 35.13 | - | |
479 | Phosphorylation | FLQRKLASLKPAERT HHHHHHHCCCHHHHH | 47.57 | - | |
481 | Ubiquitination | QRKLASLKPAERTQA HHHHHCCCHHHHHHH | 39.42 | - | |
528 | Phosphorylation | ECFRTFLSSPRHKEW HHHHHHHCCHHHHHH | 33.82 | 23186163 | |
529 | Phosphorylation | CFRTFLSSPRHKEWL HHHHHHCCHHHHHHH | 28.27 | 23186163 | |
597 | Ubiquitination | RDPQLFYKFSPILIR CCHHHHHHCCHHHHH | 31.84 | - | |
689 | Phosphorylation | YLEQAGASPHRVHYD HHHHCCCCCCCCCCC | 21.96 | 21712546 | |
717 | Phosphorylation | HRACVHVYKVLELYE HHHHHHHHHHHHHHH | 4.78 | - | |
758 | Ubiquitination | LRKKLWLKIARHVVQ HHHHHHHHHHHHHHC | 23.80 | - | |
810 | Ubiquitination | EAICSSLKAYNHHIQ HHHHHHHHHHHHHHH | 51.26 | - | |
810 | Malonylation | EAICSSLKAYNHHIQ HHHHHHHHHHHHHHH | 51.26 | 26320211 | |
810 | Acetylation | EAICSSLKAYNHHIQ HHHHHHHHHHHHHHH | 51.26 | 25953088 | |
827 | Phosphorylation | QREMEEATASAQRIR HHHHHHHHHHHHHHH | 25.15 | 25867546 | |
829 | Phosphorylation | EMEEATASAQRIRRD HHHHHHHHHHHHHHH | 22.15 | 25159151 | |
844 | Phosphorylation | LQELRGRYGTVEPQD HHHHHCCCCCCCCCC | 21.70 | 28152594 | |
846 | Phosphorylation | ELRGRYGTVEPQDKC HHHCCCCCCCCCCCC | 16.86 | 28152594 | |
901 | Ubiquitination | RLEELQRKLGAAPPP HHHHHHHHHCCCCCC | 38.01 | - | |
910 | Ubiquitination | GAAPPPAKGSARAKE CCCCCCCCCCCCHHH | 60.20 | - | |
912 | Phosphorylation | APPPAKGSARAKEAE CCCCCCCCCCHHHHC | 17.55 | 18785766 | |
916 | Ubiquitination | AKGSARAKEAEGGAA CCCCCCHHHHCCCCC | 52.48 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VPS18_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VPS18_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VPS18_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-362, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-689, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-689, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528 AND SER-529, ANDMASS SPECTROMETRY. |